Wave Life Sciences Ltd. (WVE) Q3 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to WAVE Life Sciences' third quarter 2023 financial results conference call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded and webcast. Now, I'll turn the call over to Kate Rausch, Vice President, Investor Relations and Corporate Affairs. Please go ahead. Thank you, Operator. Good morning, and thank you for joining us today to discuss our recent business progress and review WAVE's third quarter 2023 financial results. Joining me today are Dr. Paul Bono, President and Chief Executive Officer, Kyle Moran, Chief Financial Officer, Anne-Marie Lee-Kwai Chung, Chief Development Officer, Dr. Ginny Yang, SDP Translational Medicine, and Dr. Chandra Varghese, Chief Technology Officer. The press release issued this morning is available in the investor section of our website, www.wavelifesciences.com. Before we begin, I would like to remind you that discussions during this conference call will include forward-looking statements. These statements are subject to several risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors that could cause actual results to differ are discussed in the press release issued today and in our SEC filings, including our annual report on Form 10-K for the year ended December 31st, 2022, and our quarterly report on Form 10-Q for the quarter ended September 30th, 2023. We undertake no obligation to update or revise any forward-looking statement for any reason. I'd now like to turn the call over to Paul. Thanks, Kate. Good morning, and thank you all for joining us on today's call. I will begin with opening remarks. Next, Anne-Marie will provide an update on our clinical trials, and...